NEW (PAST 30 DAYS)

New (Past 30 Days)

New (Past 30 Days)

Blog Article

IntegrateRNA provides highly efficient strategies for circRNA immunoprecipitation and RIP downstream analyses. With rich experience in molecular biological experiments, our experts will offer you an optimal solution for your project. Our customized one-stop service for circRNA immunoprecipitation assay is featured with short turnaround times, competitive prices, and high reliability.
RNA is a set of very crucial and diversified effectors, mediators and regulators of biological processes, and RNA molecules are also regarded as a type of drug with high potential and plasticity. IntegrateRNA, a company specialized and expertise in RNA technologies, provides complete and professional services for RNA synthesis. Both short oligonucleotide or long RNAs, native or modified RNAs, research level or GMP level product, the services of our company could fulfill your demand.

Based on extensive experience in the lncRNA field, IntegrateRNA provides customers with a comprehensive lncRNA pull-down service, from the initial experimental design to the identification of the last interacting molecules. Our experienced scientists and advanced technologies enable us to provide consistent and high-quality data in a cost-effective manner.

Studies have shown that lncRNA has a conserved secondary structure, can interact with proteins, DNA and RNA, and participates in a variety of biological processes. With the development of high-throughput sequencing technology, more and more lncRNAs have been annotated, but the functions of most lncRNAs are still unclear. Therefore, the study of lncRNAs is a very broad unknown field and has great scientific value. RNA pull-down technology has played a vital role in the validation of lncRNA biology.

High-throughput screening for the interacting proteins of lncRNA is convenient by pull-down combined with LC-MS. IntegrateRNA utilizes LC-MS to identify captured protein complexes, and then screen specificity Interacting proteins with the target lncRNA.

Report this page